Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry M Elliott

Showing results (271-280 of 292) with videos related to

Pageof 30
Sort By:
Circulation. Genomic and Precision Medicine|August 18, 2023
Risks of Ventricular Arrhythmia and Heart Failure in Carriers of <i>RBM20</i> VariantsDouglas E Cannie, Alexandros Protonotarios, Athanasios Bakalakos, et al.
Circulation. Heart Failure|September 23, 2020
Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the <i>TTN</i> GeneMohammed Majid Akhtar, Massimiliano Lorenzini, Marcos Cicerchia, et al.
JAMA Cardiology|June 17, 2026
Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical TrialGregory D Lewis, Pablo Garcia-Pavia, Ahmad Masri, et al.
JACC. Cardiovascular Imaging|June 20, 2021
Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy: Biomarker Variability and its Impact on Clinical CareGabriella Captur, Charlotte H Manisty, Betty Raman, et al.
European Heart Journal|June 29, 2022
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculatorAlexandros Protonotarios, Riccardo Bariani, Chiara Cappelletto, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|May 2, 2025
NAXCARE: a clinical outcome registry for Naxos disease and related cardiocutaneous syndromesAdalena Tsatsopoulou, Dominic Jr Abrams, Aris Anastasakis, et al.
Circulation. Arrhythmia and Electrophysiology|November 29, 2024
Electrophysiological Phenotype-Genotype Study of Sustained Monomorphic Ventricular Tachycardia in Inherited, High Arrhythmic Risk, Left Ventricular CardiomyopathyEva Cabrera-Borrego, Francisco J Bermúdez-Jiménez, Alessio Gasperetti, et al.
Journal of Cardiovascular Translational Research|July 7, 2023
A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy PatientsEmilia Nagyova, Edgar T Hoorntje, Wouter P Te Rijdt, et al.
Journal of the American College of Cardiology|July 11, 2020
Clinical Features and Natural History of PRKAG2 Variant Cardiac GlycogenosisAngela Lopez-Sainz, Fernando Dominguez, Luis Rocha Lopes, et al.
JAMA Cardiology|August 15, 2019
Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)Gabrielle Norrish, Tao Ding, Ella Field, et al.
Pageof 30

Showing results (271-280 of 292) with videos related to

Sort By:
Pageof 30
Circulation. Genomic and Precision Medicine|August 18, 2023
Risks of Ventricular Arrhythmia and Heart Failure in Carriers of <i>RBM20</i> VariantsDouglas E Cannie, Alexandros Protonotarios, Athanasios Bakalakos, et al.
Circulation. Heart Failure|September 23, 2020
Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the <i>TTN</i> GeneMohammed Majid Akhtar, Massimiliano Lorenzini, Marcos Cicerchia, et al.
JAMA Cardiology|June 17, 2026
Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical TrialGregory D Lewis, Pablo Garcia-Pavia, Ahmad Masri, et al.
JACC. Cardiovascular Imaging|June 20, 2021
Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy: Biomarker Variability and its Impact on Clinical CareGabriella Captur, Charlotte H Manisty, Betty Raman, et al.
European Heart Journal|June 29, 2022
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculatorAlexandros Protonotarios, Riccardo Bariani, Chiara Cappelletto, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|May 2, 2025
NAXCARE: a clinical outcome registry for Naxos disease and related cardiocutaneous syndromesAdalena Tsatsopoulou, Dominic Jr Abrams, Aris Anastasakis, et al.
Circulation. Arrhythmia and Electrophysiology|November 29, 2024
Electrophysiological Phenotype-Genotype Study of Sustained Monomorphic Ventricular Tachycardia in Inherited, High Arrhythmic Risk, Left Ventricular CardiomyopathyEva Cabrera-Borrego, Francisco J Bermúdez-Jiménez, Alessio Gasperetti, et al.
Journal of Cardiovascular Translational Research|July 7, 2023
A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy PatientsEmilia Nagyova, Edgar T Hoorntje, Wouter P Te Rijdt, et al.
Journal of the American College of Cardiology|July 11, 2020
Clinical Features and Natural History of PRKAG2 Variant Cardiac GlycogenosisAngela Lopez-Sainz, Fernando Dominguez, Luis Rocha Lopes, et al.
JAMA Cardiology|August 15, 2019
Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)Gabrielle Norrish, Tao Ding, Ella Field, et al.
Pageof 30